Leaked IP Chapter Of India-EU FTA Shows TRIPS-Plus Pitfalls For India, Expert Says 12/03/2013 by Patralekha Chatterjee for Intellectual Property Watch 5 Comments Indian negotiators are reportedly under tremendous pressure to give in to the European demands for a more rigid intellectual property rights regime in the ongoing discussions on EU-India free trade agreement, suggests a leaked draft text of the chapter on IP which is being negotiated.
Digital Rights, Health Concerns As TPP Talks Continue 11/03/2013 by Intellectual Property Watch Leave a Comment As closed-door talks for the Trans-Pacific Partnership (TPP) agreement progress this week, concerns have been raised about the proposed intellectual property chapter. Industry, public health and digital liberties groups urged negotiators to consider the possible impact on investment, digital rights, access to affordable medicines, and R&D for life-saving medicines.
WTO Hears Health, Economic Considerations Of Plain Packaging For Tobacco 07/03/2013 by Catherine Saez, Intellectual Property Watch Leave a Comment In its meeting this week, the World Trade Organisation intellectual property committee heard again about the issue of plain packaging of tobacco products, as New Zealand is proposing to introduce such a regime in the country. Economic and health interests were used by those opposed and proponents to the measure.
WTO: Wide Support For LDC TRIPS Extension, With A Hitch 06/03/2013 by Catherine Saez, Intellectual Property Watch 5 Comments The World Trade Organization committee on intellectual property rights met this week and addressed a request by least developed countries for an extension of the period to enforce WTO intellectual property rules. LDCs want that the extension be extinguishable only after a country ceases to be considered as ‘least developed’, which developing countries largely supported. Developed countries, however, were hesitant about the terms of the proposed extension.
US Report: Foreign-Owned Firms Dominate IP Industries 06/03/2013 by Intellectual Property Watch 2 Comments A majority of leading firms in IP-related industries are foreign-owned, according to a new report, which argues that this should change the focus of US policymakers on domestic IP protection.
Academics Criticise Handling Of Cultural Diversity, Traditional Knowledge At International Level 06/03/2013 by Tiphaine Nunzia Caulier for Intellectual Property Watch 2 Comments At a recent conference jointly organised by the Graduate Institute of International and Development Studies (IHEID, Geneva) and the Museum of Art and History of Geneva, academics tackled the question of the preservation of culture – in its natural and cultural dimension – against the risks of globalisation.
“Works For Hire” A Key Issue As Music Stars Begin Terminating Copyright Transfers 05/03/2013 by Dugie Standeford for Intellectual Property Watch 1 Comment Courts in the United States are beginning to interpret a Copyright Act of 1976 provision allowing authors of protected works to terminate their rights assignments beginning this year. Intellectual property attorneys appear to differ over the importance of the recent rulings, but they agree that the battle line in termination cases between the recording industry and artists will be drawn over whether or not a piece of music was created for hire.
Monsanto v. Bowman: Stocktaking After Supreme Court Hearings 05/03/2013 by Catherine Saez, Intellectual Property Watch 7 Comments The United States Supreme Court recently heard oral arguments in the case opposing a US farmer to agro-industry giant Monsanto on the issue of patent exhaustion in patented seeds. Lead lawyers in the case and others offered comments on the heels of the hearing, while the Supreme Court Justices are considering the arguments and are expected to reach a decision sometime this spring.
Bayer Will Appeal India Compulsory Licence On Its Cancer Drug 05/03/2013 by Intellectual Property Watch 7 Comments German pharmaceutical manufacturer Bayer has announced it will appeal yesterday’s ruling in India that upheld a compulsory licence on one of its drugs.
India’s First Compulsory Licence Upheld, But Legal Fights Likely To Continue 04/03/2013 by Patralekha Chatterjee for Intellectual Property Watch 6 Comments New Delhi – India’s Intellectual Property Appellate Board (IPAB) today upheld the country’s first compulsory licence on a pharmaceutical product. The much-awaited verdict by Justice (Ms) Prabha Sridevan upholds the compulsory licence issued to Hyderabad-based Natco Pharma Ltd, an Indian generic drug manufacturer, which sells a much cheaper version of German pharmaceutical company Bayer AG’s kidney and liver cancer drug Nexavar in the market.